Lotus Eye (India) Performance
| LOTUSEYE | 70.57 2.14 3.13% |
Lotus Eye has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.2, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Lotus Eye's returns are expected to increase less than the market. However, during the bear market, the loss of holding Lotus Eye is expected to be smaller as well. Lotus Eye Hospital right now secures a risk of 3.0%. Please verify Lotus Eye Hospital downside variance, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Lotus Eye Hospital will be following its current price movements.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Lotus Eye Hospital are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain technical and fundamental indicators, Lotus Eye may actually be approaching a critical reversion point that can send shares even higher in April 2025. ...more
Ex Dividend Date 2023-09-18 |
1 | Lotus Eye Hospital Faces Sell Downgrade Amid Stagnant Q2 FY24-25 Performance - MarketsMojo | 01/08/2025 |
2 | Dr. Agarwals Health Care IPO High valuation calls for caution Stock Market News - Mint | 01/28/2025 |
3 | Lotus Eye Hospital Faces Flat Performance Amid Shifting Market Sentiment and Valuation Concerns - MarketsMojo | 02/10/2025 |
4 | International Womens Day 2025 Top 5 women investors in India - Stocks, portfolio, net worth - ET Now | 03/07/2025 |
| Begin Period Cash Flow | 92.8 M |
Lotus |
Lotus Eye Relative Risk vs. Return Landscape
If you would invest 6,619 in Lotus Eye Hospital on December 26, 2024 and sell it today you would earn a total of 438.00 from holding Lotus Eye Hospital or generate 6.62% return on investment over 90 days. Lotus Eye Hospital is generating 0.1483% of daily returns and assumes 3.0012% volatility on return distribution over the 90 days horizon. Simply put, 26% of stocks are less volatile than Lotus, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Lotus Eye Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lotus Eye's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Lotus Eye Hospital, and traders can use it to determine the average amount a Lotus Eye's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0494
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | LOTUSEYE | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.0 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.15 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Lotus Eye is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lotus Eye by adding it to a well-diversified portfolio.
Lotus Eye Fundamentals Growth
Lotus Stock prices reflect investors' perceptions of the future prospects and financial health of Lotus Eye, and Lotus Eye fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lotus Stock performance.
| Return On Equity | 0.0498 | ||||
| Return On Asset | 0.0312 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 1.4 B | ||||
| Shares Outstanding | 20.8 M | ||||
| Price To Book | 2.37 X | ||||
| Price To Sales | 3.00 X | ||||
| Revenue | 482.1 M | ||||
| Gross Profit | 116.89 M | ||||
| EBITDA | 79.42 M | ||||
| Net Income | 29.14 M | ||||
| Cash And Equivalents | 36.03 M | ||||
| Total Debt | 11.1 M | ||||
| Book Value Per Share | 29.26 X | ||||
| Cash Flow From Operations | 56.83 M | ||||
| Earnings Per Share | 0.24 X | ||||
| Total Asset | 666.27 M | ||||
| Retained Earnings | 135.69 M | ||||
About Lotus Eye Performance
Evaluating Lotus Eye's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Lotus Eye has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Lotus Eye has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Lotus Eye is entity of India. It is traded as Stock on NSE exchange.Things to note about Lotus Eye Hospital performance evaluation
Checking the ongoing alerts about Lotus Eye for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Lotus Eye Hospital help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lotus Eye Hospital had very high historical volatility over the last 90 days | |
| Lotus Eye Hospital is unlikely to experience financial distress in the next 2 years | |
| About 65.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: International Womens Day 2025 Top 5 women investors in India - Stocks, portfolio, net worth - ET Now |
- Analyzing Lotus Eye's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lotus Eye's stock is overvalued or undervalued compared to its peers.
- Examining Lotus Eye's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lotus Eye's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lotus Eye's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lotus Eye's stock. These opinions can provide insight into Lotus Eye's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Lotus Stock Analysis
When running Lotus Eye's price analysis, check to measure Lotus Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Eye is operating at the current time. Most of Lotus Eye's value examination focuses on studying past and present price action to predict the probability of Lotus Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Eye's price. Additionally, you may evaluate how the addition of Lotus Eye to your portfolios can decrease your overall portfolio volatility.